Direction, evidence grade, and study type are AI-generated labels (gpt-5-mini), not human-verified. Syntheses are LLM-written. "Tensions" are machine-detected candidates, not confirmed contradictions. A research-acceleration tool, not peer review.
How this is built →
1Distinct papers
7Unique collaborators
1/1OpenAlex citation coverage
Publication dates unavailable. Corpus fetch span: 2026.
Identity provenance
Provider IDs
- Openalex:
A5130408600
ORCID evidence
No valid ORCID is stored.
Observed aliases (1)
- Markus Klein (openalex, provider refresh)
Topics and outcomes in this view
Assessment themes
- Adoption: 1 paper
- Human Ai Collab: 1 paper
- Innovation: 1 paper
- Org Design: 1 paper
- Productivity: 1 paper
Claim outcomes
- Firm Productivity: 1 paper
- Organizational Efficiency: 1 paper
- Adoption Rate: 1 paper
- Innovation Output: 1 paper
Papers in the OpenAlex view
Latest stored OpenAlex author observations only. Citation counts below are from the same provider and are not combined with other services.
Scroll the table horizontally to see every column.
| Paper | Author evidence | Date | Provider citations |
|---|---|---|---|
| Pharma’s AI promise won’t be proven by accuracy metrics alone: EFMC2 calls for new impact-oriented KPIs to measure whether AI actually raises R&D productivity and drives top-line value, arguing that strategic indicators are needed to guide adoption and innovation.semantic_scholar | Markus Klein provider id |
Fetched 2026-03-25 | 0 |
Citation observation summary
OpenAlex supplied counts for 1 of 1 papers in this view; 0 are missing. The observed paper counts sum to 0 cumulative citations. This is a coverage summary, not an author score or h-index.